DNA Methylation in Serum as a Predictive Marker of Progression and Survival Following Systemic Therapy in Patients with Metastatic Breast Cancer
Investigation of an Investigational Treatment for Chronic Pain
Not Recruiting
18 years - 100 years
Female
Phase
N/A
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Breast Cancer
Age:
18 years - 100 years
Gender: Female
Who can participate: Adults aged 18 to 65 experiencing chronic pain for at least six months may be eligible. Participants must not have any other significant health conditions that could interfere with the study outcomes.
Study details: Participants will receive the investigational treatment or a placebo over a 12-week period. The study includes regular assessments of pain levels, physical health, and quality of life. A placebo is an inactive substance designed to mimic the investigational treatment to assess its true effect.
Updated on
19 Feb 2024.
Study ID: 1011003827 (0711-22)
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
